eli lilly tirzepatide patent expiry When do the patents on ZEPBOUND expire, and when will generic ZEPBOUND be available? In weight loss battle, Novo

A new wave of intentional consumption is challenging alcohol brands to innovate across formats, pricing and partnerships

Retatrutide is an investigational triple-agonist peptide that simultaneously targets GLP1, GIP, and glucagon receptors to promote weight loss, improved insulin sensitivity, and enhanced metabolic regulation in research and clinical studies.

Its hard to create positive change and build new habits if you feel tired or lack overall energy

Physician-Assisted Weight Loss -

The World Health Organisation's 2026 global guidelines on GLP-1 therapies for obesity explicitly recommend combining medication with intensive behavioural interventions, including structured goal-setting for diet and physical activity

Semaglutide works by slowing stomach emptying and reducing appetite signals in your brain